We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$1.98B
AUM Growth
+$171M
Cap. Flow
+$109M
Cap. Flow %
5.49%
Top 10 Hldgs %
35.03%
Holding
220
New
18
Increased
34
Reduced
52
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 94.16%
2 Technology 1.37%
3 Industrials 1.32%
4 Communication Services 1.26%
5 Consumer Discretionary 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
126
Microsoft
MSFT
$3.71T
$1.76M 0.09%
3,546
-1,279
-27% -$555K
V icon
127
Visa
V
$677B
$1.73M 0.09%
4,869
-1,701
-26% -$593K
WMT icon
128
Walmart Inc
WMT
$890B
$1.69M 0.09%
17,242
-6,560
-28% -$625K
KO icon
129
Coca-Cola
KO
$375B
$1.61M 0.08%
22,712
-7,050
-24% -$502K
BRK.B icon
130
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.58M 0.08%
3,250
-1,151
-26% -$585K
VZ icon
131
Verizon
VZ
$196B
$1.57M 0.08%
36,266
-10,887
-23% -$471K
TXN icon
132
Texas Instruments
TXN
$261B
$1.54M 0.08%
7,415
-2,360
-24% -$419K
INTC icon
133
Intel
INTC
$513B
$1.48M 0.08%
66,216
-18,729
-22% -$388K
NFLX icon
134
Netflix
NFLX
$309B
$1.46M 0.07%
10,890
-2,120
-16% -$240K
JNJ icon
135
Johnson & Johnson
JNJ
$625B
$1.45M 0.07%
9,472
-2,771
-23% -$426K
PG icon
136
Procter & Gamble
PG
$339B
$1.43M 0.07%
8,952
-2,861
-24% -$467K
NKE icon
137
Nike
NKE
$61.9B
$1.38M 0.07%
19,399
-5,365
-22% -$322K
XOM icon
138
ExxonMobil
XOM
$634B
$1.36M 0.07%
12,651
-3,946
-24% -$422K
OPRX icon
139
OptimizeRx
OPRX
$133M
$1.35M 0.07%
100,000
HD icon
140
Home Depot
HD
$355B
$1.34M 0.07%
3,646
-1,204
-25% -$436K
ALXO icon
141
ALX Oncology
ALXO
$290M
$1.31M 0.07%
3,158,265
PYPL icon
142
PayPal
PYPL
$50.5B
$1.29M 0.07%
17,323
-4,785
-22% -$328K
CCCC icon
143
C4 Therapeutics
CCCC
$412M
$1.29M 0.07%
900,000
PFE icon
144
Pfizer
PFE
$153B
$1.29M 0.07%
53,039
-13,761
-21% -$321K
GE icon
145
GE Aerospace
GE
$384B
$1.28M 0.06%
4,986
-689
-12% -$151K
GEV icon
146
GE Vernova
GEV
$264B
$1.28M 0.06%
2,421
-172
-7% -$71.6K
CLYM
147
Climb Bio
CLYM
$804M
$1.24M 0.06%
1,000,000
VTRS icon
148
Viatris
VTRS
$18.9B
$1.15M 0.06%
128,359
-40,620
-24% -$343K
ULTA icon
149
Ulta Beauty
ULTA
$24.3B
$1.13M 0.06%
2,410
-196
-8% -$81K
VSTM icon
150
Verastem
VSTM
$610M
$1.12M 0.06%
270,000

Similar funds

Tang Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Tang Capital Management held 220 positions worth $1.98B, up 9.4% from $1.81B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Tang Capital Management deployed $109M of net new capital in Q2 2025, opening 18 new positions and adding to 34 existing holdings. Its largest new stake was Mettler-Toledo International: 19,500 shares worth $22.9M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 95% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Dynavax Technologies, an estimated $40M trimmed.

  • Tang Capital Management's largest Q2 2025 buy was Mettler-Toledo International: 19,500 shares worth $22.9M.
  • Tang Capital Management added most to Vera Therapeutics in Q2 2025, an estimated $27M increase.
  • Tang Capital Management's biggest Q2 2025 reduction was Dynavax Technologies, cutting an estimated $40M.
  • Tang Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $29M.
  • Tang Capital Management's ten largest holdings make up 35% of its $1.98B portfolio in Q2 2025.
  • Tang Capital Management opened 18 new positions and closed 20 in Q2 2025.
  • Tang Capital Management's portfolio value rose 9.4% quarter-over-quarter to $1.98B.

Based on Tang Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.